Nature's Sunshine Products, Inc.

NATR Consumer Defensive Packaged Foods

Nature's Sunshine Products, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $480.1 million, up 5.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.95%, EPS fell 31.0% and free cash flow fell 164.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

12.64 0.00 0.00%
Market cap
$222.4M
P/E
12.4×
Fwd P/E
16.4×
Dividend yield
—
F-score
8/9
Altman Z
5.37
Beneish M
−2.83
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
121.25 0.00 0.00 25.51 13.59 12.76 0.00 22.18 36.65 19.98
Piotroski F-Score
5 5 6 6 6 7 5 8 6 8
P/S ratio
0.80 0.64 0.43 0.48 0.76 0.83 0.39 0.76 0.60 0.81
Altman Z-Score
4.39 3.80 3.51 3.53 4.28 5.02 3.89 4.93 5.02 5.37
P/FCF ratio
0.00 39.51 7.07 50.09 8.92 13.12 0.00 11.00 19.05 13.47
Altman Z″-Score (non-manufacturers)
3.43 3.32 3.26 3.89 4.93 5.31 5.23 5.35 6.04 5.82
Beneish M-Score
(2.50) (3.16) (3.19) (2.33) (2.74) (2.40) (1.93) (3.29) (2.70) (2.83)
P/Operating CF
(165.68) 88.04 20.43 56.87 27.02 25.64 46.10 35.24 22.40 39.26
P/B ratio
2.06 1.83 1.29 1.33 1.86 2.28 1.12 2.12 1.70 2.41
Price to Tangible BV
2.07 1.84 1.30 1.34 1.86 2.28 1.12 2.12 1.70 2.41
EV/Sales
0.73 0.56 0.30 0.40 0.53 0.64 0.28 0.60 0.42 0.62
EV/EBITDA
16.77 18.95 7.10 5.45 6.32 6.19 4.39 8.78 5.58 7.72
EV/Operating CF
72.89 18.04 4.93 17.03 5.41 8.19 168.64 6.51 7.57 8.44
EV/FCF
(32.72) 34.25 4.88 42.26 6.22 10.13 (17.31) 8.73 13.37 10.33
Quick Ratio
0.66 0.97 0.88 1.05 1.43 1.24 1.13 1.19 1.43 1.31
Current Ratio
1.50 1.91 1.60 1.95 2.21 2.15 2.28 2.16 2.44 2.28
Net Debt/EBITDA
(1.63) (2.92) (3.24) (1.01) (2.74) (1.83) (2.16) (2.69) (2.47) (2.43)
Debt/Assets
4.83% 7.01% 0.79% 12.52% 1.49% 0.93% 0.51% 0.00% 0.00% 0.00%
Debt/Equity
0.07 0.11 0.01 0.21 0.02 0.02 0.01 0.00 0.00 0.00
Asset Turnover
1.68 1.71 1.88 1.78 1.67 1.75 1.73 1.86 1.85 1.91
Operating CF/Net income
1.60 (0.81) (25.57) 1.26 1.77 1.20 (1.82) 2.73 3.29 1.81
Capex/Depreciation
(2.40) (0.58) 0.02 (0.48) (0.46) (0.59) (0.69) (0.89) (0.77) (0.47)
Interest Coverage
627.44 4.80 13.83 375.00 210.61 138.68 65.29 271.72 137.64 252.48
ROE
1.59% (10.27%) (0.71%) 5.41% 14.89% 18.11% (0.25%) 9.83% 4.80% 12.10%
ROA
1.05% (6.46%) (0.44%) 3.33% 9.23% 11.35% (0.16%) 6.29% 3.14% 7.78%
ROIC
5.80% 0.96% 4.68% 9.83% 19.49% 27.91% 11.52% 15.19% 16.46% 22.86%
Return on Tangible Assets
2.04% (10.97%) (0.82%) 5.92% 15.38% 20.78% (0.30%) 11.25% 5.72% 14.65%
Average Days of Receivables
8.28 9.48 7.76 7.38 6.99 7.29 12.20 7.23 7.61 6.54
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
70.40% 72.98% 72.30% 69.61% 68.13% 66.19% 67.19% 67.90% 67.04% 67.27%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.94% 0.65% 0.59% 0.59% 0.98% 0.84% 0.69% 1.10% 1.05% 1.20%
Graham Net Nets
0.08 0.12 0.22 0.17 0.21 0.18 0.41 0.22 0.30 0.20
Graham Number
4.37 0.00 0.00 7.26 14.11 16.28 0.00 12.27 8.82 14.77
Earnings Yield
0.82% (5.95%) (0.49%) 3.92% 7.36% 7.84% (0.23%) 4.51% 2.73% 5.00%
Free Cash Flow Yield
(2.79%) 2.53% 14.14% 2.00% 11.21% 7.62% (4.20%) 9.09% 5.25% 7.42%
Revenue per Share
18.21 18.11 19.08 18.75 19.72 22.36 21.83 23.36 24.41 26.67
Operating CF per Share
0.18 0.56 1.14 0.44 1.93 1.74 0.04 2.16 1.36 1.96
Capex per Share
(0.62) (0.26) 0.01 (0.26) (0.25) (0.33) (0.39) (0.55) (0.59) (0.36)
Free Cash Flow per Share
(0.43) 0.29 1.15 0.18 1.68 1.41 (0.36) 1.61 0.77 1.60
Cash per Share
1.82 2.27 2.65 2.78 4.71 4.34 3.11 4.32 4.55 5.21
Shareholders Equity per Share
7.07 6.34 6.30 6.70 8.05 8.13 7.61 8.37 8.65 8.97
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
7.07 6.34 6.30 6.70 8.05 8.13 7.61 8.37 8.65 8.97
Free Cash Flow
(8.12) 5.54 22.04 3.44 32.75 28.00 (6.92) 30.75 14.33 28.84
Working Capital
31.47 48.85 40.14 54.76 84.41 88.00 83.93 89.06 94.89 100.31
Capital Expenditures
(11.54) (4.98) 0.21 (5.10) (4.90) (6.61) (7.63) (10.48) (10.97) (6.48)
Net Current Asset Value
21.33 27.05 34.38 29.07 61.80 67.20 66.78 75.58 80.72 79.25
EV/EBIT
24.81 136.90 20.11 9.02 9.48 8.18 7.36 14.31 9.53 12.04
Capex to Sales
0.03 0.01 0.00 0.01 0.01 0.01 0.02 0.02 0.02 0.01
Price to Operating Income
27.15 157.92 29.13 10.70 13.60 10.60 10.14 18.04 13.58 15.70
Other line items
Depreciation/Fixed assets
0.07 0.12 0.15 0.18 0.20 0.22 0.24 0.26 0.36 0.42
Cash ROIC
(4.60%) 3.14% 12.76% 1.64% 12.94% 11.20% (3.32%) 12.71% 5.83% 11.29%
Accounts Receivable Turnover
44.20 41.14 43.85 48.07 52.43 54.67 36.72 38.84 49.65 53.12
Accounts Payable Turnover
15.62 19.13 20.29 19.52 18.60 14.27 15.22 17.42 15.42 15.64
Inventory Turnover
2.11 1.99 2.22 2.12 2.15 2.13 1.90 1.84 2.05 2.07
Average Days of Payables
21.29 16.90 19.91 17.12 23.38 30.67 18.97 23.25 25.08 22.11
Days of Inventory on Hand
191.04 176.60 160.39 181.32 171.85 192.36 203.04 196.60 167.31 188.29
Average Receivables
7.72 8.31 8.32 7.54 7.35 8.12 11.49 11.47 9.15 9.04
Average Payables
5.82 4.76 4.72 4.81 5.45 8.09 8.03 7.13 8.41 8.47
Average Inventory
43.05 45.82 43.05 44.36 47.17 54.27 64.40 67.42 63.17 63.88
Average Assets
203.05 200.38 194.11 203.04 231.28 254.19 244.33 239.78 245.31 251.00
Average Common Equity
134.33 126.07 120.15 125.00 143.34 159.32 154.23 153.29 160.27 161.27

Fold the line items

Columns are period end dates